Neil Kumar

Affiliations

  • Chief Executive Officer at Bridgebio Pharma Inc. (BBIO), 2025-05-20
  • Director at Lianbio (LIAN), 2021-11-09
  • Chief Executive Officer at Eidos Therapeutics Inc. (EIDX), 2019-07-09
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EIDX $29.90 882,353 $26,382,795.88 24,575,501 2019-07-03 Filing
EIDX $25.93 1,103,848 $28,622,778.64 23,693,148 2019-05-24 Filing
EIDX $13.96 2,664 $37,189.44 22,589,300 2018-12-10 Filing
EIDX $13.29 37,989 $504,873.81 22,586,636 2018-12-10 Filing
EIDX $14.36 4,860 $69,789.60 22,548,647 2018-12-07 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BBIO $33.40 75,000 $2,504,977.50 4,798,447 2025-05-20 Filing
BBIO $33.75 400 $13,499.00 217,404 2025-05-19 Filing
BBIO $33.32 25,756 $858,264.61 217,804 2025-05-19 Filing
BBIO $34.11 75,000 $2,558,025.00 4,873,447 2025-04-22 Filing
BBIO $36.87 75,000 $2,764,942.50 4,948,447 2025-03-25 Filing